menu_open Columnists
Aimee Donnellan

Aimee Donnellan

Reuters

We use cookies to provide some features and experiences in QOSHE

More information  .  Close

EU carmaker turnaround hopes look doomed

15.09.2026 3

Reuters

Aimee Donnellan

For Novartis, M&A is both a disease and cure

For Novartis, M&A is both a disease and cure
11.09.2026 3

Reuters

Aimee Donnellan

Cost crisis will fuel risky consumer growth dash

Cost crisis will fuel risky consumer growth dash
10.09.2026 9

Reuters

Aimee Donnellan

VW’s rescue wagon shifts into first gear

04.09.2026 10

Reuters

Aimee Donnellan

How to improve Pernod Ricard's turnaround cocktail

27.08.2026 10

Reuters

Aimee Donnellan

AstraZeneca's blocked M&A signals tough CEO finale

24.08.2026 10

Reuters

Aimee Donnellan

Munich Re goes bottom feeding in murky cyber world

19.08.2026 10

Reuters

Aimee Donnellan

Morrisons LBO pain has a cure: Sainsbury's M&A

24.07.2026 10

Reuters

Aimee Donnellan

VW’s bold plan can barely keep it on the road

24.07.2026 10

Reuters

Aimee Donnellan

Why Nestlé will defy the consumer breakup trend

21.07.2026 10

Reuters

Aimee Donnellan

Uber feast marks end of easy food delivery M&A

17.07.2026 10

Reuters

Aimee Donnellan

Cybersecurity costs will shrink AI's profit boost

14.07.2026 20

Reuters

Aimee Donnellan

Northern Ireland's post-Brexit boost is in peril

17.06.2026 20

Reuters

Aimee Donnellan

AI could tarnish Ireland’s low-risk sheen

08.06.2026 30

Reuters

Aimee Donnellan

Bayer’s Monsanto debacle sows bitter M&A lessons

01.06.2026 40

Reuters

Aimee Donnellan

SpaceX hype screens out most but not all rival IPOs

22.05.2026 30

Reuters

Aimee Donnellan

Primark owner gives frumpy spin on breakup vogue

21.04.2026 40

Reuters

Aimee Donnellan

Weight loss drugs face first economic stress test

13.04.2026 30

Reuters

Aimee Donnellan

Past errors haunt consumer giants' new Africa push

24.03.2026 50

Reuters

Aimee Donnellan

Novo Nordisk's illness offers painful lessons

03.03.2026 60

Reuters

Aimee Donnellan

Vaccine slump risks a downward financial spiral

19.02.2026 40

Reuters

Aimee Donnellan

Europe-US relisting trend: $1 trln more in store

09.01.2026 30

Reuters

Aimee Donnellan

Graduate job cull spells doom for college degrees

23.12.2025 40

Reuters

Aimee Donnellan

Unilever ice cream spinoff needs a scoop of hope

05.12.2025 40

Reuters

Aimee Donnellan

Big Coffee’s next brew may be smaller and weaker

17.11.2025 50

Reuters

Aimee Donnellan

Big Pharma Trump toadying stores up bigger battles

11.11.2025 30

Reuters

Aimee Donnellan

Pfizer’s obesity win is new formula for pharma M&A

10.11.2025 30

Reuters

Aimee Donnellan

AI sets up Kodak moment for global consultants

24.10.2025 50

Reuters

Aimee Donnellan

Nestlé cuts are appetiser for bigger shake-up

16.10.2025 30

Reuters

Aimee Donnellan

AstraZeneca’s New York shift augurs London exodus

07.10.2025 30

Reuters

Aimee Donnellan

Obesity kings’ buffet is slimmer than it looks

02.10.2025 40

Reuters

Aimee Donnellan

AstraZeneca’s game of exit chess puts UK in check

29.09.2025 30

Reuters

Aimee Donnellan

Big Pharma’s tariff win leaves lingering aches

26.09.2025 40

Reuters

Aimee Donnellan

Trump investment gifts only partly offset UK gloom

18.09.2025 30

Reuters

Aimee Donnellan

Budweiser brews some sobering mega-deal lessons

16.09.2025 40

Reuters

Aimee Donnellan

AstraZeneca picks canny time to shake down the UK

15.09.2025 40

Reuters

Aimee Donnellan

Latest Nestlé CEO exit is chance for bigger reset

02.09.2025 30

Reuters

Aimee Donnellan

GSK revenue hole raises chances of risky M&A move

25.07.2025 30

Reuters

Aimee Donnellan

Big Pharma pioneers the TOFU tariff trade

22.07.2025 30

Reuters

Aimee Donnellan

Big Cannabis puts its growth hopes in dud buds

14.07.2025 40

Reuters

Aimee Donnellan

Donald Trump’s tariff scattergun will miss target

09.07.2025 40

Reuters

Aimee Donnellan

Shein disclosure row flags London’s IPO quandary

08.07.2025 40

Reuters

Aimee Donnellan